Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Gelman

Showing results (121-130 of 135) with videos related to

Pageof 14
Sort By:
Cancer|September 15, 1994
The relationship between microscopic margins of resection and the risk of local recurrence in patients with breast cancer treated with breast-conserving surgery and radiation therapyS J Schnitt, A Abner, R Gelman, et al.
International Journal of Radiation Oncology, Biology, Physics|February 3, 2000
The significance of extracapsular extension of axillary lymph node metastases in early-stage breast cancerS Hetelekidis, S J Schnitt, B Silver, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1990
The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breastR Holland, J L Connolly, R Gelman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 14, 2000
Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrenceC C Park, M Mitsumori, A Nixon, et al.
Cancer|August 15, 1980
Combination chemotherapy with adriamycin-cyclophosphamide for advanced ovarian carcinomaL M Parker, C T Griffiths, R A Yankee, et al.
Cancer|November 1, 1996
Pathologic margin involvement and the risk of recurrence in patients treated with breast-conserving therapyI Gage, S J Schnitt, A J Nixon, et al.
Journal of Virology|May 18, 2001
Membrane-fusing capacity of the human immunodeficiency virus envelope proteins determines the efficiency of CD+ T-cell depletion in macaques infected by a simian-human immunodeficiency virusB Etemad-Moghadam, D Rhone, T Steenbeke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Repetitive cycles of cyclophosphamide, thiotepa, and carboplatin intensification with peripheral-blood progenitor cells and filgrastim in advanced breast cancer patientsC L Shapiro, L Ayash, I J Webb, et al.
Breast Cancer Research and Treatment|May 7, 2013
A phase II study of bevacizumab in combination with vinorelbine and trastuzumab in HER2-positive metastatic breast cancerN U Lin, D S Seah, R Gelman, et al.
Genes, Chromosomes & Cancer|December 29, 1999
Prevalence of germline truncating mutations in ATM in women with a second breast cancer after radiation therapy for a contralateral tumorT D Shafman, S Levitz, A J Nixon, et al.
Pageof 14

Showing results (121-130 of 135) with videos related to

Sort By:
Pageof 14
Cancer|September 15, 1994
The relationship between microscopic margins of resection and the risk of local recurrence in patients with breast cancer treated with breast-conserving surgery and radiation therapyS J Schnitt, A Abner, R Gelman, et al.
International Journal of Radiation Oncology, Biology, Physics|February 3, 2000
The significance of extracapsular extension of axillary lymph node metastases in early-stage breast cancerS Hetelekidis, S J Schnitt, B Silver, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1990
The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breastR Holland, J L Connolly, R Gelman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 14, 2000
Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrenceC C Park, M Mitsumori, A Nixon, et al.
Cancer|August 15, 1980
Combination chemotherapy with adriamycin-cyclophosphamide for advanced ovarian carcinomaL M Parker, C T Griffiths, R A Yankee, et al.
Cancer|November 1, 1996
Pathologic margin involvement and the risk of recurrence in patients treated with breast-conserving therapyI Gage, S J Schnitt, A J Nixon, et al.
Journal of Virology|May 18, 2001
Membrane-fusing capacity of the human immunodeficiency virus envelope proteins determines the efficiency of CD+ T-cell depletion in macaques infected by a simian-human immunodeficiency virusB Etemad-Moghadam, D Rhone, T Steenbeke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Repetitive cycles of cyclophosphamide, thiotepa, and carboplatin intensification with peripheral-blood progenitor cells and filgrastim in advanced breast cancer patientsC L Shapiro, L Ayash, I J Webb, et al.
Breast Cancer Research and Treatment|May 7, 2013
A phase II study of bevacizumab in combination with vinorelbine and trastuzumab in HER2-positive metastatic breast cancerN U Lin, D S Seah, R Gelman, et al.
Genes, Chromosomes & Cancer|December 29, 1999
Prevalence of germline truncating mutations in ATM in women with a second breast cancer after radiation therapy for a contralateral tumorT D Shafman, S Levitz, A J Nixon, et al.
Pageof 14